Werewolf Therapeutics, Inc. (HOWL)
Pharmaceutical Preparations
Latest Price
$0.35
TTM P/E
--
Normalized P/E
0.02
Div Yield
--
Book Value
0.25
P/B Ratio
1.41
Institutional Ownership
28.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 6.68M | $5.0M | 13.75% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.22M | $1.0M | 2.51% | -- | 2026-03-31 |
| MPM BIOIMPACT LLC | 1.21M | $1.0M | 2.49% | -184.7K | 2026-03-31 |
| Lynx1 Capital Management LP | 657.8K | -- | 1.35% | +1.9K | 2026-03-31 |
| SPHERA FUNDS MANAGEMENT LTD. | 626.8K | -- | 1.29% | -- | 2026-03-31 |
| DC Funds, LP | 589.1K | -- | 1.21% | -- | 2026-03-31 |
| Squadron Capital Management LLC | 563.5K | -- | 1.16% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 516.2K | -- | 1.06% | -161.5K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 389.5K | -- | 0.80% | +53.6K | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 264.6K | -- | 0.54% | -473.0K | 2026-03-31 |